BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11719376)

  • 21. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.
    Fowler DH; Gress RE
    Leuk Lymphoma; 2000 Jul; 38(3-4):221-34. PubMed ID: 10830730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide gene.
    Casucci M; Perna SK; Falcone L; Camisa B; Magnani Z; Bernardi M; Crotta A; Tresoldi C; Fleischhauer K; Ponzoni M; Gregori S; Caligaris Cappio F; Ciceri F; Bordignon C; Cignetti A; Bondanza A; Bonini C
    Mol Ther; 2013 Feb; 21(2):466-75. PubMed ID: 23299798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental study of the inhibiting effect of the lentiviral vector mediated herpes simplex virus-thymidine kinase/ganciclovir on GVHD].
    Xu KL; Zhu F; Du B; Gao F; Cheng H; Pan XY
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):303-7. PubMed ID: 17877157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.
    Yang YG; Sergio JJ; Pearson DA; Szot GL; Shimizu A; Sykes M
    Blood; 1997 Dec; 90(11):4651-60. PubMed ID: 9373279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors.
    Verzeletti S; Bonini C; Marktel S; Nobili N; Ciceri F; Traversari C; Bordignon C
    Hum Gene Ther; 1998 Oct; 9(15):2243-51. PubMed ID: 9794208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reaction.
    van der Zouwen B; Kruisselbrink AB; Frederik Falkenburg JH; Jedema I
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):760-9. PubMed ID: 24607556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation.
    Bordignon C; Bonini C; Verzeletti S; Nobili N; Maggioni D; Traversari C; Giavazzi R; Servida P; Zappone E; Benazzi E
    Hum Gene Ther; 1995 Jun; 6(6):813-9. PubMed ID: 7548281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of alloresponses after bone marrow transplantation using donor T cells expressing a thymidine kinase suicide gene.
    Drobyski WR; Gendelman M
    Leuk Lymphoma; 2002 Oct; 43(10):2011-6. PubMed ID: 12481900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice.
    Di Ianni M; Terenzi A; Falzetti F; Bartoli A; Di Florio S; Benedetti R; Venditti G; Alfonsi D; De Ioanni M; Falini B; Tabilio A
    Cancer Gene Ther; 2002 Sep; 9(9):756-61. PubMed ID: 12189525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suicide gene therapy of graft-versus-host disease: immune reconstitution with transplanted mature T cells.
    Cohen JL; Boyer O; Klatzmann D
    Blood; 2001 Oct; 98(7):2071-6. PubMed ID: 11567992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ganciclovir-mediated elimination of HSV-Tk+ T cells and cure of graft-vs-host disease in an allogeneic bone marrow transplantation model in the rat.
    Weijtens M; van Spronsen A; Hagenbeek A; de Weger R; Martens A
    Exp Hematol; 2004 Oct; 32(10):962-9. PubMed ID: 15504552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G; Truitt RL; Johnson BD
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes.
    Junker K; Koehl U; Zimmerman S; Stein S; Schwabe D; Klingebiel T; Grez M
    Gene Ther; 2003 Jul; 10(14):1189-97. PubMed ID: 12833128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of combined cytostatic cyclosporin A and cytolytic suicide gene therapy on the prevention of experimental graft-versus-host disease.
    Maury S; Litvinova E; Boyer O; Benard L; Bruel S; Klatzmann D; Cohen JL
    Gene Ther; 2002 Feb; 9(3):201-7. PubMed ID: 11859423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft.
    Tiberghien P; Ferrand C; Lioure B; Milpied N; Angonin R; Deconinck E; Certoux JM; Robinet E; Saas P; Petracca B; Juttner C; Reynolds CW; Longo DL; Hervé P; Cahn JY
    Blood; 2001 Jan; 97(1):63-72. PubMed ID: 11133743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological defects after suicide gene therapy of experimental graft-versus-host disease.
    Cohen JL; Lacroix-Desmazes S; Charlotte F; Lejeune L; Martin PJ; Klatzmann D; Boyer O
    Hum Gene Ther; 1999 Nov; 10(16):2701-7. PubMed ID: 10566898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT.
    Mammadli M; Huang W; Harris R; Sultana A; Cheng Y; Tong W; Pu J; Gentile T; Dsouza S; Yang Q; Bah A; August A; Karimi M
    Front Immunol; 2020; 11():593863. PubMed ID: 33324410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.
    Ciceri F; Bonini C; Gallo-Stampino C; Bordignon C
    Cytotherapy; 2005; 7(2):144-9. PubMed ID: 16040393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.